dc.contributor.author | Yuksel, Murat | |
dc.contributor.author | Ademoglu, Evin | |
dc.contributor.author | Kaya, Aysem | |
dc.contributor.author | Can, Gunay | |
dc.contributor.author | Yuksel, Husniye | |
dc.contributor.author | Onat, Altan | |
dc.date.accessioned | 2021-03-04T15:04:44Z | |
dc.date.available | 2021-03-04T15:04:44Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Kaya A., Onat A., Yuksel H., Can G., Yuksel M., Ademoglu E., "Lipoprotein(a)-activated immunity, insulin resistance and new-onset diabetes", POSTGRADUATE MEDICINE, cilt.129, sa.6, ss.611-618, 2017 | |
dc.identifier.issn | 0032-5481 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_84d78287-3b03-4de8-802d-371dd52847cc | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/90352 | |
dc.identifier.uri | https://doi.org/10.1080/00325481.2017.1342508 | |
dc.description.abstract | Objectives: Some evidence suggests that serum lipoprotein[Lp](a) may be inversely linked to type-2 diabetes. We aimed to determine in nondiabetic people the relationship of serum [Lp](a) with insulin resistance and new-onset diabetes (NOD). | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.title | Lipoprotein(a)-activated immunity, insulin resistance and new-onset diabetes | |
dc.type | Makale | |
dc.relation.journal | POSTGRADUATE MEDICINE | |
dc.contributor.department | Dicle Üniversitesi , , | |
dc.identifier.volume | 129 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 611 | |
dc.identifier.endpage | 618 | |
dc.contributor.firstauthorID | 91147 | |